Preclinical Development of Bivalent Chimeric Antigen Receptors Targeting Both CD19 and CD22

por Qin, Haiying, Ramakrishna, Sneha, Nguyen, Sang, Fountaine, Thomas J., Ponduri, Anusha, Stetler-Stevenson, Maryalice, Yuan, Constance M., Haso, Waleed, Shern, Jack F., Shah, Nirali N., Fry, Terry J.
Publicado 2018

Characterization of extramedullary disease in B-ALL and response to CAR T-cell therapy

por Holland, Elizabeth M., Yates, Bonnie, Ling, Alex, Yuan, Constance M., Wang, Hao-Wei, Stetler-Stevenson, Maryalice, LaLoggia, Michael, Molina, John C., Lichtenstein, Daniel A., Lee, Daniel W., Ligon, John A., Shalabi, Haneen, Ahlman, Mark A., Shah, Nirali N.
Publicado 2022

Expression of the muscle-associated gene MYF6 in hairy cell leukemia

por Arons, Evgeny, Zhou, Hong, Sokolsky, Mark, Gorelik, Daniel, Potocka, Katherine, Davies, Sarah, Fykes, Erin, Still, Katherine, Edelman, Daniel C., Wang, Yonghong, Meltzer, Paul S., Raffeld, Mark, Wiestner, Adrian, Xi, Liqiang, Wang, Hao-Wei, Stetler-Stevenson, Maryalice, Yuan, Constance, Kreitman, Robert J.
Publicado 2020

Efficacy of second CAR-T (CART2) infusion limited by poor CART expansion and antigen modulation

por Holland, Elizabeth M, Molina, John C, Dede, Kniya, Moyer, Daniel, Zhou, Ting, Yuan, Constance M, Wang, Hao-Wei, Stetler-Stevenson, Maryalice, Mackall, Crystal, Fry, Terry J, Panch, Sandhya, Highfill, Steven, Stroncek, David, Little, Lauren, Lee, Daniel W, Shalabi, Haneen, Yates, Bonnie, Shah, Nirali
Publicado 2022

Long term follow-up of a phase II study of cladribine with concurrent rituximab with hairy cell leukemia variant

por Chihara, Dai, Arons, Evgeny, Stetler-Stevenson, Maryalice, Yuan, Constance, Wang, Hao-Wei, Zhou, Hong, Raffeld, Mark, Xi, Liqiang, Steinberg, Seth M., Feurtado, Julie, James-Echenique, Lacey, Tai, Chin-Hsien, Patel, Keyur P., Braylan, Raul C., Calvo, Katherine R., Maric, Irina, Dulau-Florea, Alina, Kreitman, Robert J.
Publicado 2021

Inotuzumab ozogamicin in pediatric patients with relapsed/refractory acute lymphoblastic leukemia

por Bhojwani, Deepa, Sposto, Richard, Shah, Nirali N., Rodriguez, Vilmarie, Yuan, Constance, Stetler-Stevenson, Maryalice, O’Brien, Maureen M., McNeer, Jennifer L., Quereshi, Amrana, Cabannes, Aurelie, Schlegel, Paul, Rossig, Claudia, Dalla-Pozza, Luciano, August, Keith, Alexander, Sarah, Bourquin, Jean-Pierre, Zwaan, Michel, Raetz, Elizabeth A., Loh, Mignon L., Rheingold, Susan R.
Publicado 2018

Correction: Inotuzumab ozogamicin in pediatric patients with relapsed/refractory acute lymphoblastic leukemia

por Bhojwani, Deepa, Sposto, Richard, Shah, Nirali N., Rodriguez, Vilmarie, Yuan, Constance, Stetler-Stevenson, Maryalice, O’Brien, Maureen M., McNeer, Jennifer L., Quereshi, Amrana, Cabannes, Aurelie, Schlegel, Paul, Rossig, Claudia, Dalla-Pozza, Luciano, August, Keith, Alexander, Sarah, Bourquin, Jean-Pierre, Zwaan, Michel, Raetz, Elizabeth A., Loh, Mignon L., Rheingold, Susan R.
Publicado 2019

Avelumab, a PD‐L1 Inhibitor, in Combination with Hypofractionated Radiotherapy and the Abscopal Effect in Relapsed Refractory Multiple Myeloma

por Kazandjian, Dickran, Dew, Alexander, Hill, Elizabeth, Ramirez, Elizabeth Gil, Morrison, Candis, Mena, Esther, Lindenberg, Liza, Yuan, Constance, Maric, Irina, Wang, Hao‐Wei, Calvo, Katherine, Dulau‐Florea, Alina, Roswarski, Joseph, Emanuel, Michael, Braylan, Raul, Turkbey, Baris, Choyke, Peter, Camphausen, Kevin, Stetler‐Stevenson, Maryalice, Steinberg, Seth M., Figg, William D., C. Jones, Jennifer
Publicado 2021

Direct in vivo Evidence for Increased Proliferation of CLL Cells in Lymph Nodes Compared to Bone Marrow and Peripheral Blood

por Herndon, Thomas M., Chen, Shih-Shih, Saba, Nakhle S., Valdez, Janet, Emson, Claire, Gatmaitan, Michelle, Tian, Xin, Hughes, Thomas E., Sun, Clare, Arthur, Diane C., Stetler-Stevenson, Maryalice, Yuan, Constance M., Niemann, Carsten U., Marti, Gerald E., Aue, Georg, Soto, Susan, Farooqui, Mohammed Z.H., Herman, Sarah E.M., Chiorazzi, Nicholas, Wiestner, Adrian
Publicado 2017

CD22-CAR T Cells Induce Remissions in CD19-CAR Naïve and Resistant B-ALL

por Fry, Terry J., Shah, Nirali N., Orentas, Rimas J., Stetler-Stevenson, Maryalice, Yuan, Constance M., Ramakrishna, Sneha, Wolters, Pamela, Martin, Staci, Delbrook, Cindy, Yates, Bonnie, Shalabi, Haneen, Fountaine, Thomas J., Shern, Jack F., Majzner, Robbie G., Stroncek, David F., Sabatino, Marianna, Feng, Yang, Dimitrov, Dimiter S., Zhang, Ling, Nguyen, Sang, Qin, Haiying, Dropulic, Boro, Lee, Daniel W., Mackall, Crystal L.
Publicado 2017

Blinatumomab Nonresponse and High-Disease Burden Are Associated With Inferior Outcomes After CD19-CAR for B-ALL

por Myers, Regina M., Taraseviciute, Agne, Steinberg, Seth M., Lamble, Adam J., Sheppard, Jennifer, Yates, Bonnie, Kovach, Alexandra E., Wood, Brent, Borowitz, Michael J., Stetler-Stevenson, Maryalice, Yuan, Constance M., Pillai, Vinodh, Foley, Toni, Chung, Perry, Chen, Lee, Lee, Daniel W., Annesley, Colleen, DiNofia, Amanda, Grupp, Stephan A., John, Samuel, Bhojwani, Deepa, Brown, Patrick A., Laetsch, Theodore W., Gore, Lia, Gardner, Rebecca A., Rheingold, Susan R., Pulsipher, Michael A., Shah, Nirali N.
Publicado 2022

Preinfusion factors impacting relapse immunophenotype following CD19 CAR T cells

por Lamble, Adam J., Myers, Regina M., Taraseviciute, Agne, John, Samuel, Yates, Bonnie, Steinberg, Seth M., Sheppard, Jennifer, Kovach, Alexandra E., Wood, Brent, Borowitz, Michael J., Stetler-Stevenson, Maryalice, Yuan, Constance M., Pillai, Vinodh, Foley, Toni, Chung, Perry, Chen, Lee, Lee, Daniel W., Annesley, Colleen, DiNofia, Amanda, Grupp, Stephan A., Verneris, Michael R., Gore, Lia, Laetsch, Theodore W., Bhojwani, Deepa, Brown, Patrick A., Pulsipher, Michael A., Rheingold, Susan R., Gardner, Rebecca A., Shah, Nirali N.
Publicado 2022